NEW YORK (GenomeWeb News) – Stratos Product Development said today it is partnering with nanoMR to develop an instrument to rapidly isolate multiple cell types and more rapidly detect pathogens.
The instrument will be built on nanoMR's Pathogen Capture System, and will allow clinicians to begin appropriate antibiotic treatment sooner, leading to better patient outcomes, Seattle-based Stratos said.
"Stratos' development expertise, combined with nanoMR's chemistry and research, creates an ideal team to deliver an optimal solution for the market," Jim Macemon, vice president of product development for nanoMR, said in a statement.
Based in Albuquerque, NM, nanoMr develops diagnostic systems for isolating rare cell types, using an immunomagnetic capture process that can capture cells for phenotypic analysis or extracted DNA for molecular analysis.
Stratos will develop a cost-effective cassette and processing regimen with an input of up to a 10 milliliter blood sample and an output of 50 microliters containing purified DNA, Stratos said. In addition to developing the instrument, Stratos is performing hardware and software design with ISO 13485 design controls. It also is developing manufacturing strategies and performing verification activities with output to support CE certification for clinical trials in Europe.